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(57) ABSTRACT 
An endoluminal graft system comprising an endoluminal 
graft including a framework and a flexible fabric surround-
ing the framework, a deflection means configured for place-
ment through an opening to a branching vessel, and a 
delivery catheter configured to position the endoluminal 
graft within a primary vessel. A method of implanting the 
endoluminal graft includes positioning the endoluminal 
graft within a primary vessel with a leading edge of the 
endoluminal graft adjacent to an opening to a branching 
vessel. A deflecting means is positioned through the opening 
to the branching vessel adjacent to the leading edge of the 
endoluminal graft. The endoluminal graft is then advanced 
along the length of the primary vessel with the deflection 
means engaging the leading edge of the endoluminal graft to 
form a scallop along the leading edge of the endoluminal 
graft. 
14 Claims, 14 Drawing Sheets 
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ENDOLUMINAL GRAFT SYSTEM AND 
METHOD OF IMPLANTING THE SAME 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
2 
intended seal zone of the endoluminal graft. However, 
scallops require custom manufacture of a graft based on the 
patient's anatomy, an issue which is complicated when more 
than one scallop is required. Furthermore, extreme care must 
5 be taken to ensure that the scallops are properly aligned with 
the branch vessel during deployment of the endoluminal 
graft in order to avoid obstructing blood flow into the branch 
vessel. 
The present application is a continuation of U.S. patent 
application Ser. No. 15/352,516 filed on Nov. 15, 2016, 
which claims priority to U.S. Provisional Patent Application 
Ser. No. 62/255,496 filed on Nov. 15, 2015, the entire 10 
disclosures of which are incorporated herein by reference. 
SUMMARY OF THE INVENTION 
The present invention is an endoluminal graft system and 
method of implanting the same in which scallops are formed 
in-situ during the delivery and deployment of the endolu-
15 minal graft, thereby ensuring proper alignment of the scallop 
with the branching vasculature and obviating the need for 
custom manufacturing of grafts with preformed scallops. 
TECHNICAL FIELD 
The present invention relates to an endoluminal graft 
system and method of implanting the same. In particular, the 
present invention relates to a system and method in which 
scallops are formed in-situ during the delivery and deploy-
ment of an endoluminal graft. 
BACKGROUND OF THE INVENTION 
An aneurysm is a degenerative dilation of a portion of a 
blood vessel that can ultimately lead to rupture of the vessel 
and life-threatening blood loss. As shown in FIG. 1, one of 
the most common sites of an aneurysm 105 is the infra-renal 
aorta 101 between the renal arteries 102 and the iliac vessels 
106. 
Referring now to FIG. 2, endovascular aneurysm repair 
(EVAR) is a minimally invasive procedure, which involves 
placing a tubular prosthesis 110 within the diseased blood 
vessel to act as an impervious liner which prevents the 
systemic pressure from pushing on the aneurysm 105. In 
particular, such prostheses 110 are generally made of a 
blood-impervious fabric such as polytetrafluorethylene 
(PTFE) or polyester (PET) that is supported along at least a 
portion of its length by a framework or skeleton. The 
framework or skeleton is commonly a metal ( e.g., nitinol, 
stainless steel, chromium cobalt, etc.) or an injectable poly-
mer. To be effective, the prosthesis must achieve circumfer-
ential wall apposition ( or seal) with the inner wall of a 
healthy portion of the blood vessel, or vessels, proximal and 
distal to the aneurysm 105. For standard EVAR, the proxi-
mal seal is made in a healthy portion 104 of the aorta 101 
distal to the openings 103 of the renal arteries 102. As shown 
in FIG. 2, since most infra-renal aneurysms extend to the 
terminal bifurcation of the aorta 101, most endovascular 
prostheses 110 for this location incorporate a bifurcated 
design, allowing for the distal seal to be achieved in each of 
the iliac vessels 106. 
Referring still to FIG. 2, many endovascular prostheses 
110 consist of a flat-topped fabric supported by a framework 
configured as a series of peaks and indentations. To achieve 
an effective seal, the proximal end of the graft 110 must have 
circumferential wall contact with the healthy portion 104 of 
the aorta 101. It is generally recommended that the longi-
tudinal length of the healthy portion 104 of the aorta 101 be 
at least 15 mm to achieve a seal of sufficient length to ensure 
a long-term successful seal. However, in some cases, the 
aneurysm 105 arises too close to the renal arteries 102 to 
achieve this length of seal. 
One known solution is to use an endoluminal graft with a 
scallop formed in the fabric of the endoluminal graft. A 
scallop, as used herein, is a deflection or discontinuity of the 
normally straight edge of the fabric of the endoluminal graft. 
Such scallops, can allow preservation of flow to important 
branch vessels such as the renal arteries that arise in the 
An exemplary endoluminal graft, or graft, used as part of 
the system and method of the present invention generally 
20 comprises a framework and a flexible fabric surrounding the 
framework. The framework of the graft includes a plurality 
of curvilinear elements with an uppermost element defining 
a plurality of alternating peaks and indentations. Further-
more, the flexible fabric defines a leading edge which 
25 initially extends between the peaks substantially flat across 
the indentations defined by the framework of the graft. In 
this way, the leading edge of the flexible fabric is also the 
leading edge of the graft. Furthermore, because a portion of 
the flexible fabric extends above the framework (i.e., across 
30 the indentations), the leading edge of the flexible fabric is 
deformable, as further discussed below. 
In a first step of an exemplary implementation of the 
method of the present invention, the graft is positioned 
within a primary vessel, such as the aorta, extending through 
35 an aneurysm and into a healthy portion of the aorta with the 
leading edge of the flexible fabric adjacent to an opening to 
a branching vessel, or vessels, such as the renal arteries. As 
previously mentioned, when the graft is first positioned 
within the aorta, the leading edge of the flexible fabric 
40 extends substantially flat between the peaks of the frame-
work. 
After positioning the graft with the leading edge adjacent 
to the openings of the renal arteries, a deflection means, for 
example a balloon, is positioned through the opening of each 
45 of the renal arteries and subsequently inflated. In other 
words, a distal portion of the balloon is positioned and 
temporarily secured within the renal artery while a proximal 
portion of the balloon remains within the aorta itself. The 
balloon therefore acts as a physical extension of the renal 
50 arteries into the aorta. 
After the balloons are positioned and inflated, the graft is 
advanced along the length of the aorta, such that the balloons 
engage the leading edge of the flexible fabric and cause the 
flexible fabric to deflect and form scallops along the leading 
55 edge of the flexible fabric and within the indentations of the 
framework. Advantageously, since the balloons are inflated 
so as to be secured within the renal arteries, the scallops are 
aligned with each of the renal arteries. That is to say, the 
system and method of the present invention are configured 
60 such that the balloons, or other such deflection means, align 
the indentations of the framework with the renal arteries so 
that the resulting scallops are also properly aligned with the 
renal arteries. In particular, as the graft is advanced along the 
length of the aorta and the balloons begin to deflect the 
65 flexible fabric, the balloons engage the indentations of the 
underlying framework. As the balloons slide down the 
framework and into the indentations, the balloons cause the 
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graft to rotate so as to aligned the indentation with the 
balloon extending from the renal artery. The resulting scal-
lops formed within the indentation are therefore aligned with 
the balloons and no scallops are formed along the portion of 
the leading edge where the balloons are not present, as 5 
further discussed below. 
The balloons are, in some exemplary implementations of 
the method of the present invention, introduced by a distal 
approach, such that the balloons pass through the graft itself 
before being positioned through the openings of the renal 10 
arteries, but in other exemplary implementations of the 
present invention, the balloons are introduced by a proximal 
approach. 
4 
FIG. 10 depicts the proximal seal zone of FIG. 9 after the 
graft is advanced and each balloon has formed a scallop in 
the leading edge of the flexible fabric; 
FIG.11 depicts the proximal seal zone ofFIG.10 after the 
tethers are detached; 
FIG. 12 depicts a proximal seal zone of another exem-
plary endoluminal graft of the present invention with two 
balloons, introduced by a distal approach, positioned and 
inflated within each of the renal arteries; 
FIG. 13 depicts a proximal seal zone of another exem-
plary endoluminal graft of the present invention; and 
FIG. 14 depicts a distal seal zone of another exemplary 
endoluminal graft of the present invention with a scallop 
aligned with the opening to a branching artery. 
DESCRIPTION OF THE INVENTION 
The present invention relates to the design of endoluminal 
graft systems, which are medical devices designed to treat 
vascular pathology such as aneurysms or dissections and 
methods of implanting the same. More specifically, the 
invention is an endoluminal graft system, and method of 
implanting the same, in which scallops are formed in-situ 
during the delivery and deployment of the endoluminal 
graft, thereby ensuring proper alignment of the scallop with 
the branching vasculature and obviating the need for custom 
manufacturing of grafts with preformed scallops. 
Referring now to FIGS. 3-6, an exemplary endoluminal 
graft, or graft, 210 used as part of the system and method of 
After the scallops are formed along the leading edge of the 
15 
graft, the balloons are deflated and removed from the 
openings to the renal arteries. The graft is now positioned 
within the aorta with a proximal seal made in the healthy 
portion of the aorta proximal to the aneurysm. Advanta-
geously, in the exemplary system and method of the present 20 
invention, it is only the portions of the leading edge of graft 
which are aligned with the openings to the renal arteries (i.e., 
where the balloons were previously positioned) that is 
deflected to create the scallops. The remaining portion of the 
leading edge is not deflected and extends above the openings 25 
to the renal arteries. As such, even when the aneurysm is 
relatively close to the renal arteries, the area of the flexible 
fabric in contact with the healthy portion of the aorta 
provides a sufficient seal while still preserving blood flow to 
the renal arteries. 30 the present invention generally comprises a framework 220 
and a flexible fabric 230 surrounding the framework 220. 
The framework 220 of the graft 210 includes a plurality of 
curvilinear elements with an uppermost element defining a 
plurality of alternating peaks 224 and indentations 226. 
Further features and advantages of the present invention 
will become evident to those of ordinary skill in the art after 
a study of the description, figures, and non-limiting 
examples in this document. 
DESCRIPTION OF THE DRAWINGS 
FIG. 1 depicts an aneurysm in the infra-renal aorta of a 
patient's vasculature; 
FIG. 2 depicts an endoluminal graft known in the prior art 
deployed within the vasculature of FIG. 1; 
FIG. 3 depicts a proximal seal zone of an exemplary 
endoluminal graft of the present invention positioned via a 
delivery catheter; 
35 Furthermore, the flexible fabric 230 defines a leading edge 
232 which, as shown in FIG. 3, initially extends between the 
peaks 224 substantially flat across the indentations 226 
defined by the framework 220 of the graft 210. In this way, 
the leading edge 232 of the flexible fabric 230 is also the 
40 leading edge 232 of the graft 210. Furthermore, because a 
portion of the flexible fabric 230 extends above the frame-
work 220 (i.e., across the indentations 226), the leading edge 
232 of the flexible fabric 230 is deformable, as further 
discussed below. 
FIG. 4Adepicts the proximal seal zone of FIG. 3 with two 45 
balloons, introduced by a distal approach, positioned and 
inflated within each of the renal arteries; 
Referring now specifically to FIG. 3, in a first step of an 
exemplary implementation of the method of the present 
invention, the graft 210 is positioned within a primary vessel 
of a patient, such as the patient's aorta 101, extending 
through an aneurysm 105 and into a healthy portion 104 of 
FIG. 4B depicts the proximal seal zone of FIG. 3 with two 
balloons, introduced by a proximal approach, positioned and 
inflated within each of the renal arteries; 
FIG. SA depicts the proximal seal zone of FIG. 4A after 
the graft is advanced and each balloon has formed a scallop 
in the leading edge of the flexible fabric; 
FIG. 5B depicts the proximal seal zone of FIG. 4B after 
the graft is advanced and each balloon has formed a scallop 
in the leading edge of the flexible fabric; 
FIG. 6 is an oblique view of the graft of FIG. SA after the 
balloons are removed showing the scallops aligned with the 
openings to the renal arteries; 
50 the aorta 101 with the leading edge 232 of the flexible fabric 
230 adjacent to an opening 103 to a branching vessel, or 
vessels, such as the renal arteries 102. As previously men-
tioned, when the graft 210 is first positioned within the aorta 
101, the leading edge 232 of the flexible fabric 230 extends 
55 substantially flat between the peaks 224 of the framework 
220. 
FIG. 7 depicts the proximal seal zone of FIG. SA with 60 
stents deployed in each of the renal arteries; 
Although not shown in the Figures, it should be under-
stood by one skilled in the art that the graft 210 may be 
positioned by way of the patient's femoral artery or by other 
common techniques. Typically, the graft 210 is placed in 
communication with the interior of the patient's vessel while 
the graft 210 is in an undeployed configuration which is 
substantially narrower than the fully deployed configuration. 
In some embodiments, a delivery sheath or other similar 
device known in the art, may further assist in placement of 
the graft 210, however, in other embodiments a delivery 
sheath may not be needed. In either event, as shown in FIG. 
FIG. 8 depicts a proximal seal zone of another exemplary 
endoluminal graft of the present invention positioned via a 
delivery catheter having a plurality of tethers; 
FIG. 9 depicts the proximal seal zone of FIG. 8 with two 65 
balloons, introduced by a distal approach, positioned and 
inflated within each of the renal arteries; 
US 10,667,899 Bl 
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3, the delivery sheath and/or graft 210 are guided by a 
delivery catheter 200 into position within the aorta 101, and, 
subsequently, the graft 210 is deployed. As shown in the 
Figures, the delivery catheter 200 includes a nose cone 204 
which is advanced along a guidewire 202 and which pre- 5 
cedes a guidewire lumen 206 that is disposed around the 
guidewire 202. 
fabric 230 when the graft 210 is advanced along the length 
of the aorta 101. Likewise, a cutting balloon or other similar 
device can be used to cut or tear the flexible fabric 230 in 
addition to, or instead of deflecting the leading edge 232 of 
the flexible fabric 230. 
Referring once again to FIG. 3, in this exemplary imple-
mentation of the method of the present invention, the graft 
210 is shown in a substantially deployed configuration 
within the aorta 101 such that the flexible fabric 230 of the 
Referring now specifically to FIG. 4A, after positioning 
the graft 210 with the leading edge 232 adjacent to the 
openings 103 of the renal arteries 102, a deflection means 10 
300, which in the embodiment shown in FIG. 4A is a balloon 
300, is positioned through the opening 103 of each of the 
renal arteries 102 and subsequently inflated. In other words, 
and as shown in FIG. 4A, a distal portion of the balloon 300 
graft 210 is adjacent to the inner wall of the aorta 101 with 
the leading edge 232 of the flexible fabric 230 immediately 
distal to the openings 103 of the renal arteries 102. Further-
more, in this exemplary implementation of the method of the 
present invention, the graft 210 remains in the substantially 
is positioned and temporarily secured within the renal artery 15 
102 while a proximal portion of the balloon 300 remains 
within the aorta 101 itself. The balloon 300 therefore acts as 
deployed configuration while the balloons 300 are posi-
tioned through the opening 103 of the renal arteries 102 
(shown in FIGS. 4A and 4B) and while the graft 210 is 
advanced along the length of the aorta 101 (shown in FIGS. 
SA and 5B). In some other exemplary implementations, 
a physical extension of the renal arteries 102 into the aorta 
101. 
Referring now specifically to FIG. SA, after the balloons 
300 are positioned and inflated, the graft 210 is advanced 
along the length of the aorta 101, such that the balloons 300 
engage the leading edge 232 of the flexible fabric 230 and 
cause the flexible fabric 230 to deflect and form scallops 240 
along the leading edge 232 of the flexible fabric 230 and 
within the indentations 226 of the framework 220. Advan-
tageously, since the balloons 300 are inflated so as to be 
secured within the renal arteries 102, the scallops 240 are 
aligned with each of the renal arteries 102. That is to say, the 
system and method of the present invention are configured 
such that the balloons 300, or other such deflection means, 
align the indentations 226 of the framework 220 with the 
renal arteries 102 so that the resulting scallops 240 are also 
properly aligned with the renal arteries 102. In particular, as 
the graft 210 is advanced along the length of the aorta 101 
and the balloons 300 begin to deflect the flexible fabric 230, 
the balloons 300 engage the indentations 226 of the under-
lying framework 220. As the balloons 300 slide down the 
framework 220 and into the indentations 226, the balloons 
300 cause the graft 210 to rotate so as to aligned the 
indentation 226 with the balloon 300 extending from the 
renal artery 102. As shown in FIG. SA, the resulting scallops 
240 formed within the indentation 226 are therefore aligned 
with the balloons 300 and no scallops are formed along the 
portion of the leading edge 232 where the balloons 300 are 
not present, as further discussed below. 
As shown in FIGS. 4A and SA, in this exemplary imple-
mentation of the method of the present invention, the 
balloons 300 are introduced by a distal approach, such that 
the balloons 300 pass through the graft 210 itself before 
being positioned through the openings 103 of the renal 
arteries 102. Referring now specifically to FIGS. 4B and 5B, 
in another exemplary implementation of the present inven-
tion, the balloons 300 are introduced by a proximal 
approach. As shown in FIG. 5B, after the balloons 300 are 
positioned and inflated, the graft 210 is still advanced along 
the length of the aorta 101, such that the leading edge 232 
of the flexible fabric 230 engages the balloons 300 forming 
the scallops 240 within the indentations 226 of the frame-
work 220 while leaving the remainder of the leading edge 
232 straight in substantially the same manner as discussed 
above with respect to FIGS. 4A and SA. 
Regardless of the particular direction of approach, it is 
contemplated that, rather than a balloon, the deflection 
means can be a sheath or other similar device known in the 
art which, after being introduced into the renal arteries 102, 
is capable of deflecting the leading edge 232 of the flexible 
20 however, a dual stage graft can be used, in which the graft 
is first partially deployed within the aorta, allowing for 
adjustments in the position of the graft. The graft is then 
fully deployed at which point the graft is effectively con-
nected to the aorta with a sufficient seal between the graft 
25 and the inner wall of the aorta. For example, in some 
particular embodiments, a dual stage graft is partially 
deployed prior to positioning the balloons, or other similar 
deflection means, within the openings of the renal arteries. 
The dual stage graft is then fully deployed after the scallops 
30 are formed along the leading edge of the endoluminal graft. 
Of course, depending on the particular form of the graft 
provided, other variations in the order of the steps of 
positioning the graft, positioning the deflection means, 
advancing the graft, forming the scallops, and deploying the 
35 graft are also contemplated without departing from the spirit 
and scope of the present invention. 
Regardless of the particular implementation of the method 
of forming the scallops of the present invention, and refer-
ring now specifically to FIG. 6, after the scallops 240 are 
40 formed along the leading edge 232 of the graft 210, the 
balloons 300 are deflated and removed from the openings 
103 to the renal arteries 102. The graft 210 is now positioned 
within the aorta 101 with a proximal seal made in the healthy 
portion 104 of the aorta 101 proximal to the aneurysm 105. 
45 Advantageously, in the exemplary system and method of the 
present invention, it is only the portion ( or portions) of the 
leading edge 232 of graft 210 which is aligned with the 
openings 103 to the renal arteries 102 (i.e., where the 
balloons 300 were previously positioned) that is deflected to 
50 create the scallops 240. The remaining portion of the leading 
edge 232 is not deflected and extends above the openings 
103 to the renal arteries 102. As such, even though the 
aneurysm 105 shown in FIGS. 3-6 is relatively close to the 
renal arteries 102, the area of the flexible fabric 230 in 
55 contact with the healthy portion 104 of the aorta 101 
provides a sufficient seal while still preserving blood flow to 
the renal arteries 102. 
In addition to the graft 210 described above, and referring 
now to FIG. 7, in some exemplary embodiments of the 
60 present invention, the system further includes stents 400 
which are positioned adjacent to the scallop 240 of the graft 
210 and extending through the opening 103 to the renal 
artery 102. In particular, in some exemplary implementa-
tions of the method of the present invention, the stents 400 
65 are positioned after the scallops 240 are formed and the 
balloons 300 are deflated and removed from the openings 
103. It is contemplated that the stents 400 help maintain the 
US 10,667,899 Bl 
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shape and alignment of the scallops 240, thus limiting the 
possibility of a subsequent decrease in flow to the renal 
arteries 102 caused, for example, by a shift in the position of 
the graft 210 within the aorta 101. The stents 400 included 
8 
fabric 1230 and cause the flexible fabric 1230 to deflect and 
form scallops 1240 along the leading edge 1232 and within 
the indentation 1226 of the framework 1220 in substantially 
in the system of the present invention can be any one of a 5 
number of stents known in the art. 
the same manner as described above with respect to FIG. 
SA. As mentioned above, the tethers 1250 provide additional 
control when forming the scallops 1240 by allowing the 
Referring now to FIGS. 8-11, in another exemplary 
embodiment of the system of the present invention, a 
delivery catheter 1200 and endoluminal graft 1210 are 
provided similar to the delivery catheter 200 and endolumi- 10 
nal graft 210 described above with respect to FIGS. 3-6, 
except the delivery catheter 1200 shown in FIGS. 8-11 
further includes a plurality of tethers 1250 that connect the 
nosecone 1204 of the delivery catheter 1200 to the peaks 
1224 of the metal framework 1220 of the graft 1210. With 15 
respect to the graft 1210 in particular, similar to the graft 210 
described above, the graft 1210 shown in FIGS. 8-11 com-
prises a framework 1220 of curvilinear elements and a 
flexible fabric 1230 surrounding the framework 1220. The 
uppermost curvilinear element of the framework 1220 20 
includes a plurality of alternating peaks 1224 and indenta-
tions 1226 with a leading edge 1232 of the flexible fabric 
1230 extending between the peaks 1224 substantially flat 
across the indentations 1226 defined by the framework 1220 
graft 1210 to be pulled upward by the plurality of tethers 
1250, as opposed to simply being pushed upward. Except 
where stated otherwise above, all other aspects of the system 
and method of the present invention shown and described 
above with respect to FIGS. 8-10 are substantially the same 
as described above with respect to FIGS. 3-6. 
Referring now to FIG. 11, as a further refinement of the 
present invention, it is contemplated that, in some embodi-
ments, the tethers 1250 are selectively connected to the 
peaks 1224 of the framework 1220 of the graft 1210. As 
such, the tethers 1250 can subsequently detach from the 
graft 1210 for removal along with the delivery catheter 1200 
after forming the scallops 1240. 
Referring now to FIG. 12, in another exemplary embodi-
ment of the present invention, an exemplary endoluminal 
graft 2210 is provided similar to the exemplary endoluminal 
graft 210 described above with respect to FIGS. 3-6, except 
the graft 2210 shown in FIG. 12 further includes a plurality 
of the graft 1210. 
The delivery catheter 1200 is also substantially the same 
as the delivery catheter 200 described above with respect to 
FIG. 3-6 and includes a nose cone 1204 which is advanced 
along a guidewire 1202 and which precedes a guidewire 
lumen 1206 that is disposed around the guidewire 1202, but, 
as previously mentioned, the system shown in FIGS. 8-11 
includes a plurality of tethers 1250 that connect the peaks 
1224 of the metal framework 1220 of the graft 1210 to the 
nosecone 1204 of the delivery catheter 1200. The tethers 
1250 provide a connection between the delivery catheter 
1200 and the leading edge 1232 of the graft 1210 which 
facilitates the placement of the graft 1210 and formation of 
the scallops 1240, as discussed below. 
Referring now specifically to FIG. 8, the graft 1210 is 
initially positioned within the aorta 101 in substantially the 
same manner as described above with respect to FIG. 3 
except that the tethers 1250 provide additional control in the 
placement of the leading edge 1232 adjacent to the openings 
103 of the renal arteries 102. Specifically, by advancing the 
guidewire lumen 1206 along the guidewire 1202, the nose 
cone 1204 is also advanced, which, in tum pulls the graft 
1210 along the length of the aorta 101 by way of the tethers 
1250. As such, the graft 1210 can advantageously be 
advanced by a pulling mechanism in addition to a pushing 
mechanism. 
Referring now to FIG. 9, after positioning the graft 1210, 
a balloon 1300, is positioned through the opening 103 of 
each of the renal arteries 102 and subsequently inflated, in 
substantially the same marmer as describe above with 
respect to FIG. 4A. Of note, in the exemplary implementa-
tion shown in FIG. 9, the balloons 1300 are introduced with 
a distal approach such that the balloons 1300 pass through 
the graft 1210 itself before being passed between two of the 
tethers 1250 and positioned through the openings 103 of the 
renal arteries 102. In other implementations of the present 
invention, however, the balloons 1300 are instead intro-
duced by a proximal approach in substantially the same 
manner as described above with respect to FIG. 4B. 
Regardless, and referring now to FIG. 10, after the 
balloons 1300 are positioned and inflated, the graft 1210 is 
advanced along the length of the aorta 101, such that the 
balloons 1300 engage the leading edge 1232 of the flexible 
25 oftransrenal fixation portions 2260 which are secured to the 
healthy portion 104 of the aorta 101 distal of the graft 2210, 
thus further assuring that the graft 2210 is effectively 
secured to the healthy portion 104 of the aorta 101 and an 
effective seal is formed proximal to the aneurysm 105. With 
30 respect to the graft 2210 in particular, and similar to the 
exemplary grafts 210, 1210 described above, the graft 2210 
shown in FIG. 12 comprises a framework 2220 of curvilin-
ear elements and a flexible fabric 2230 surrounding the 
framework 2220. The uppermost curvilinear element of the 
35 framework 2220 includes a plurality of alternating peaks 
2224 and indentations 2226 with a leading edge 2232 of the 
flexible fabric 2230 that initially extends between the peaks 
2224 substantially flat across the indentations 2226 defined 
by the framework 2220 of the graft 2210 and which ulti-
40 mately forms the scallops 2240 in the indentations 2226 
shown in FIG. 12. The delivery catheter 2200 shown in FIG. 
12 is also substantially the same as the delivery catheter 200 
described above with respect to FIGS. 3-6 and includes a 
nose cone 2204 which is advanced along a guidewire 2202 
45 and which precedes a guidewire lumen 2206 that is disposed 
around the guidewire 2202. In the embodiment shown in 
FIG. 12, each of the transrenal fixation portions 2260 are 
connected to two adjacent peaks 2224 of the framework 
2220 of the graft 2210 and extend away from the leading 
50 edge 2232, terminating at a hook 2264 configured to engage 
the interior wall of the healthy portion 140 of the aorta 101 
when deployed. 
Referring still to FIG. 12, with the inclusion of the 
transrenal fixation portions 2260, each of the balloons 2300 
55 must pass through one of the transrenal fixation portions 
2260 and above the leading edge 2232 of the flexible fabric 
2230 when being positioned through the openings 103 of 
each of the renal arteries 102. In at least some embodiments, 
the flexible fabric 2230 of the graft 2210 is radiographically 
60 "invisible" making it difficult to determine the exact position 
of the leading edge 2232 of the flexible fabric 2230 and, 
therefore, the position of the balloons 2300 in relation to the 
leading edge 2232 of the flexible fabric 2230. As such, in 
this exemplary embodiment shown in FIG. 12, a plurality of 
65 radiographic markers 2262 are positioned at the intersection 
of the transrenal fixation portions 2260 and the peaks 2224 
of the metal framework 2220. The radiographic markers 
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2262 allow an operate to visually monitor the position of the 
markers 2262, and thus the leading edge 2232 of the flexible 
fabric 2230, in relation to the balloons 2300 and/or renal 
arteries 102 to ensure that the balloons 2300 extend between 
one of the transrenal fixation portions 2260 and the leading 5 
edge 2232 of the flexible fabric 2230. As shown in FIG. 12, 
when the scallops 2240 are formed, the balloons 2300 are 
substantially below the line of markers 2262 and therefore, 
an operator can ensure that the scallops 2240 are appropri-
ately formed within the indentations 2226 of the metal 10 
framework 2220 of the graft 2210. Except where stated 
otherwise above, all other aspects of the system and method 
10 
4242 is formed at the distal seal zone of another exemplary 
endoluminal graft 4210. The endoluminal graft 4210 is 
substantially the same as the endoluminal graft 210 
described above with respect to FIGS. 3-6 except that the 
scallop 4242 is formed at a distal edge 4234 of the graft 
4210. With respect to the graft 4210 in particular, similar to 
the graft 210 described above, the graft 4210 shown in FIG. 
14 comprises a framework 4220 of curvilinear elements and 
a flexible fabric 4230 surrounding the framework 4220. The 
lowermost curvilinear element of the framework 4220 
includes a plurality of alternating peaks 4224 and indenta-
tions 4226 with a distal edge 4234 of the flexible fabric 4230 
initially extending between the peaks 4224 substantially flat 
of the present invention shown and described above with 
respect to FIG. 12 are substantially the same as the system 
and method described above with respect to FIGS. 3-6. 
Referring now to FIG. 13, in another exemplary system of 
the present invention, an endoluminal graft 3210 is provided 
which includes additional features which assist in securing 
the graft 3210 to the healthy portion 104 of the aorta 101 and 
15 
across the indentations 4226 defined by the framework 4220 
of the graft 4210. In an exemplary implementation of the 
method of the present invention, the graft 4210 is first 
positioned within the aorta 101 and extending through the 
aneurysm 105 and into a healthy portion 107 of the aorta 101 
distal to the aneurysm 105 with the distal edge 4234 of the 
flexible fabric 4230 positioned adjacent to an opening to a 
branching artery 108. Next, a balloon 4300 is positioned 
through the opening to the branching artery 108 and subse-
quently inflated and the graft 4210 is advanced along the 
length of the aorta 101, such that the balloon 4300 engages 
the distal edge 4234 of the flexible fabric 4230 causing the 
flexible fabric 4230 to deflect and form a scallop 4242 in 
substantially the same manner previously discussed. After 
securing the graft 4210 in place, the balloon 4300 is then 
deflated and removed. 
Although the above implementations of the exemplary 
method of the present invention are described with respect 
to implanting the endoluminal graft within the aorta of a 
patient, it is of course, understood that similar methods are 
applicable to other blood vessels of the patient where an 
aneurism, or other similarly diseased portion of the blood 
vessel, is positioned near one or more branching arteries. 
One of ordinary skill in the art will recognize that addi-
tional embodiments are possible without departing from the 
teachings of the present invention. This detailed description, 
and particularly the specific details of the exemplary 
embodiments disclosed therein, is given primarily for clarity 
of understanding, and no unnecessary limitations are to be 
understood therefrom, for modifications will become obvi-
a forming an effective seal proximal to the aneurysm 105. 20 
Similar to the exemplary endoluminal grafts 210, 1210, 
2210 described above, the endoluminal graft 3210 shown in 
FIG. 13 comprises a framework 3220 of curvilinear ele-
ments and a flexible fabric 3230 surrounding the framework 
3220. The uppermost curvilinear element of the framework 25 
3220 includes a plurality of alternating peaks 3224 and 
indentations 3226 with a leading edge 3232 of the flexible 
fabric 3230 initially extending between the peaks 3224 
substantially flat across the indentations 3226 defined by the 
framework 3220 of the graft 3210. Furthermore, and similar 30 
to the exemplary graft 2210 shown in FIG. 12, the graft 3210 
shown in FIG. 13, further includes transrenal fixation por-
tions 3260, 3266 as well as a plurality of radiographic 
markers 3262. The radiographic markers 3262 shown in 
FIG. 13 are substantially similar to the radiographic markers 35 
2262 described above with respect to FIG. 12, but the 
transrenal fixation portions 3260, 3266 comprise both a 
mid-crown of fixation portions 3260 and a top-crown of 
fixation portions 3266. Furthermore, unlike any of the 
previously describe grafts, the graft 3210 shown in FIG. 13 40 
also includes two sealing rings 3268 which are injectable 
with a polymer. One such exemplary graft 3210 is the 
OVATION® graft which is produced by TriVascular, Inc. of 
Santa Rosa, Calif. (OVATION® is a registered trademark of 
TriVascular, Inc. of Santa Rosa, Calif.). 
In an exemplary implementation of the method of the 
present invention which uses a graft 3210 having both a 
mid-crown 3260 and a top-crown 3266 of fixation portions, 
the first step of deploying the graft 3210 is to release the 
mid-crown of fixation portions 3260. A balloon (not shown) 50 
is passed through one of the fixation portions 3260 of the 
mid-crown and above the leading edge 3232 of the flexible 
fabric 3230 when being positioned through the opening 103 
45 ous to those skilled in the art upon reading this disclosure 
and may be made without departing from the spirit or scope 
of the present invention. 
What is claimed is: 
1. A method of implanting an endoluminal graft, com-
prising: 
positioning an endoluminal graft within a primary vessel 
with a leading edge of the endoluminal graft adjacent to 
an opening to a branching vessel; 
positioning a deflection means through the opening to the 
branching vessel adjacent to the leading edge of the 
endoluminal graft; 
advancing the endoluminal graft along the length of the 
primary vessel such that the deflection means engages 
the leading edge of the endoluminal graft and forms a 
scallop in-situ along the leading edge of the endolumi-
nal graft. 
of the renal artery 102. The balloon is then inflated and the 
scallop (not visible) is formed substantially as described 55 
above. The top-crown of fixation portions 3266 is then 
released, securing the graft 3210 in place in the aorta 101. 
Finally, polymer is injected into the sealing rings 3268 as 
well as other channels built into the graft 3210 forming a 
seal with the healthy portion 104 of the aorta 101. Except 60 
where stated otherwise above, all other aspects of the system 
and method of the present invention shown and described 
above with respect to FIG. 13 are substantially the same as 
the system and method described above with respect to 
FIGS. 3-6. 
2. The method of claim 1, wherein the endoluminal graft 
includes a framework defining a plurality of indentations 
65 adjacent to the leading edge of the endoluminal graft and a 
flexible fabric surrounding the framework and forming the 
leading edge of the endoluminal graft, and wherein the 
Referring now to FIG. 14, in another exemplary imple-
mentation of the method of the present invention, a scallop 
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method further comprises a step of aligning one of the 
plurality of indentations with the opening to the branching 
vessel. 
12 
10. The method of claim 1, and further comprising a step 
of positioning a stent adjacent to the scallop so as to extend 
through the opening to the branching vessel. 
3. The method of claim 2, wherein the scallop is formed 
within one of the plurality of indentations. 
4. The method of claim 2, wherein, upon advancing the 
endoluminal graft along the length of the primary vessel, the 
deflection means aligns the one of the plurality of indenta-
tions with the opening to the branching vessel. 
11. The method of claim 9, and further comprising a step 
5 of positioning a stent adjacent to the scallop such that the 
stent extends through the opening to the branching vessel. 
12. A method of implanting an endoluminal graft, com-
prising: 
5. The method of claim 1, wherein the endoluminal graft 
10 
includes a framework defining a plurality of indentations 
adjacent to the leading edge of the endoluminal graft, a 
flexible fabric surrounding the framework and forming the 
leading edge of the endoluminal graft, and one or more 
transrenal fixation portions connected to the framework and 
extending away from the leading edge of the endoluminal 15 
graft, and wherein the method further includes passing the 
deflection means through one of the transrenal fixation 
portions and above the leading edge of the endoluminal 
graft. 
6. The method of claim 1, wherein the deflection means 20 
is a balloon, and wherein the method further comprises 
inflating the balloon within the branching vessel. 
7. The method of claim 1, wherein the step of positioning 
the endoluminal graft comprises: 
inserting the endoluminal graft within the primary vessel 25 
when the endoluminal graft is in an undeployed con-
figuration; and 
deploying the endoluminal graft such that the leading 
edge of the endoluminal graft is adjacent to an inner 
wall of the primary vessel. 
8. The method of claim 1, and further comprising: 
partially deploying the endoluminal graft prior to posi-
tioning the deflection means through the opening to the 
branching vessel; and 
30 
fully deploying the endoluminal graft after forming the 35 
scallop along the leading edge of the endoluminal graft. 
9. The method of claim 1, and further comprising a step 
of removing the deflection means from the opening to the 
branching vessel. 
providing an endoluminal graft having a leading edge, the 
endoluminal graft including a framework defining a 
plurality of indentations adjacent to the leading edge of 
the endoluminal graft, a flexible fabric surrounding the 
framework and forming the leading edge of the endolu-
minal graft, and one or more transrenal fixation por-
tions which are each connected to the framework and 
extend away from the leading edge of the endoluminal 
graft; 
positioning the endoluminal graft within a primary vessel 
with the leading edge of the endoluminal graft adjacent 
to an opening to a branching vessel; 
passing a deflection means through one of the transrenal 
fixation portions and above the leading edge of the 
endoluminal graft; 
positioning the deflection means through the opening to 
the branching vessel; 
advancing the endoluminal graft along the length of the 
primary vessel such that the deflection means engages 
the leading edge of the endoluminal graft and forms a 
scallop in-situ along the leading edge of the endolumi-
nal graft and within one of the plurality of indentations. 
13. The method of claim 12, wherein, upon advancing the 
endoluminal graft along the length of the primary vessel, the 
deflection means aligns the one of the plurality of indenta-
tions with the opening to the branching vessel. 
14. The method of claim 13, wherein the deflection means 
is a balloon, and wherein the method further comprises 
inflating the balloon within the branching vessel. 
* * * * * 
